Publications by authors named "Stuart Mair"

Claim this Profile
F
First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy Participants.
Matthew Davidson, Xilin Chen, Amanda Mathis, Sylvia Dobo, Melanie Cornpropst, Stuart Mair

J Clin Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production.
Rajula Gaur, Kofi A Mensah, Jason Stricker, Mary Adams, Anastasia Parton, Stuart Mair

Arthritis Res Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges.
Shahzadgai Khan, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Stuart Mair

Front Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of ulimorelin, a ghrelin agonist, on liquid gastric emptying and colonic transit in humans.
Joyce James, Stuart Mair, Walter Doll, Erik Sandefer, David Wurtman

Neurogastroenterol Motil· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appetite and food intake results from phase I studies of anamorelin.
Robert A Blum, Stuart Mair, Elizabeth M Duus

J Cachexia Sarcopenia Muscle· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, disposition and metabolic pathway of amiselimod (MT-1303) in healthy volunteers in a mass balance study.
Takayuki Kifuji, Shinsuke Inoue, Megumi Furukawa, Begonya Perez Madera, Takahiro Goto, Stuart J Mair

Xenobiotica· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation.
Réka Angi, Tamás Solymosi, Nikoletta Erdősi, Tamás Jordán, Balázs Kárpáti, Stuart Mair

AAPS PharmSciTech· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.
Susan Reijntjes, Muna Albayaty, James Bush, Joseph Cheriyan, Anthea Cromie, Stuart Mair

Front Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect.
Tamás Solymosi, Zsolt Ötvös, Réka Angi, Betti Ordasi, Tamás Jordán, Stuart Mair

Cancer Chemother Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, Excretion, and Pharmacokinetics of Selumetinib, an MEK1/2 inhibitor, in Healthy Adult Male Subjects.
Angela W Dymond, Colin Howes, Christine Pattison, Karen So, Gabriella Mariani, Stuart Mair

Clin Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration.
Andrew McEwen, Laura Lawrence, Randy Hoover, Lloyd Stevens, Stuart Mair

Xenobiotica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absorption, metabolism and excretion of [14C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans.
Namtae Kim, Lorna Patrick, Stuart Mair, Lloyd Stevens, Gill Ford

Xenobiotica· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potential.
Karthick Vishwanathan, Stuart Mair, Anshul Gupta, James Atherton, Jacqueline Clarkson-Jones

Drug Metab Dispos· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans.
Yoshinobu Nakamaru, Yoshiharu Hayashi, Ruriko Ikegawa, Shuji Kinoshita, Begonya Perez Madera, Stuart Mair

Xenobiotica· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Netupitant PET imaging and ADME studies in humans.
Tulla Spinelli, Selma Calcagnile, Claudio Giuliano, Giorgia Rossi, Corinna Lanzarotti, Stuart Mair

J Clin Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial.
Cornelius F Waller, Miguel Bronchud, Stuart Mair, Rodeina Challand

Ann Hematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial.
Cornelius F Waller, Miguel Bronchud, Stuart Mair, Rodeina Challand

Ann Hematol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of PNEUMOVAX II manufactured by a new process in older adults.
Stuart Mair, Anne Fiquet, Gilles Meghlaoui, Stephane Thomas, Emilio Ledesma

Hum Vaccin· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis